DE1264445B - Process for the preparation of 2,6-dichloro-5-fluoropyrimidine - Google Patents

Process for the preparation of 2,6-dichloro-5-fluoropyrimidine

Info

Publication number
DE1264445B
DE1264445B DER36298A DER0036298A DE1264445B DE 1264445 B DE1264445 B DE 1264445B DE R36298 A DER36298 A DE R36298A DE R0036298 A DER0036298 A DE R0036298A DE 1264445 B DE1264445 B DE 1264445B
Authority
DE
Germany
Prior art keywords
fluoropyrimidine
dichloro
fluorouracil
preparation
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DER36298A
Other languages
German (de)
Inventor
Dr Kailash Kumar Gauri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Robugen GmbH
Original Assignee
Robugen GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robugen GmbH filed Critical Robugen GmbH
Priority to DER36298A priority Critical patent/DE1264445B/en
Publication of DE1264445B publication Critical patent/DE1264445B/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)

Description

Verfahren zur Herstellung von 2, 6-Dichlor-5-fluorpyrimidin Die Erfindung betrifft ein Verfahren zur Herstellung von 2,6-Dichlor-5-fluorpyrimidin. Gemäß der Erfindung wird diese Verbindung hergestellt, indem man ein l-Alkyl-5-fluoruracil in Gegenwart von Phosphorsäure bzw. geringen Mengen Wasser mit Phosphoroxychlorid bei Rückflußtemperatur umsetzt.Process for the preparation of 2,6-dichloro-5-fluoropyrimidine The invention relates to a process for the preparation of 2,6-dichloro-5-fluoropyrimidine. According to the Invention this compound is prepared by adding a l-alkyl-5-fluorouracil in the presence of phosphoric acid or small amounts of water with phosphorus oxychloride converts at reflux temperature.

An diesem Verfahren ist überraschend, daß es in einer Stufe gelingt, das Ausgangsprodukt gleichzeitig zu entalkylieren und zu halogenieren. Ein solcher Reaktionsablauf war bei derartigen Heterocyclen bisher nicht bekannt. What is surprising about this process is that it succeeds in one step to dealkylate and halogenate the starting product at the same time. Such a The course of the reaction in such heterocycles was not previously known.

Die nach dem Verfahren der Erfindung hergestellte Verbindung ist ein wichtiges Zwischenprodukt für die Herstellung von cytostatisch wirksamen Antimetaboliten, beispielsweise 5-Fluoruracil und 5-Fluorcytosin. The compound made by the method of the invention is an important intermediate for the production of cytostatic antimetabolites, for example 5-fluorouracil and 5-fluorocytosine.

Das 2,6-Dichlor-5-fluorpyrimidin wurde bisher in 84,50/0iger Ausbeute hergestellt aus 5-Fluoruracil, das wiederum aus 5-Äthylisothioharnstoff und dem Kaliumsalz von ol-Fluor-P-hydroxyacrylsäureäthylester über das 2-Äthylmercapto-5-fluor-6-hydroxypyrimidin in nur 17,28°/Oiger Ausbeute, bezogen auf das Harnstoffderivat, erhältlich ist. Das gemäß der Erfindung als Ausgangsstoff verwendbare l-Äthyl-5-fluoruracil ist hingegen erhältlich aus N-Äthylharnstoff und Fluormalonsäurediäthylester über 1 -Äthyl-5-fiuor-barbitursäure und dann l-Äthyl-4-chlor-5-fluoruracil in 640/0der Ausbeute, bezogen auf das Harnstoffderivat. The 2,6-dichloro-5-fluoropyrimidine has so far been in 84.50/0 yield made from 5-fluorouracil, which in turn is made from 5-ethylisothiourea and the Potassium salt of ethyl ol-fluoro-P-hydroxyacrylate via 2-ethylmercapto-5-fluoro-6-hydroxypyrimidine is available in only 17.28% yield, based on the urea derivative. The usable according to the invention as a starting material is l-ethyl-5-fluorouracil on the other hand, available from N-ethylurea and fluoromalonic acid diethyl ester via 1 -Ethyl-5-fluorobarbituric acid and then l-ethyl-4-chloro-5-fluorouracil in 640/0der Yield based on the urea derivative.

Beispiel 600 mg 1-Äthyl-5-fluoruracil (F.:131"C) werden mit zwei Tropfen Wasser und 5 mol Phosphoroxychlorid 8 Stunden unter Rückfluß erhitzt. Das überschüssige Phosphoroxychlorid wird dann im Vakuum abdestilliert und der Rückstand mit Eis-Äther-Gemisch zersetzt. Die Ätherschicht wird mit Natriumsulfat entwässert und abfiltriert. Der Äther wird abdestilliert und der Rückstand im Vakuum fraktioniert. Example 600 mg of 1-ethyl-5-fluorouracil (F.:131 "C) are mixed with two Drops of water and 5 mol of phosphorus oxychloride heated under reflux for 8 hours. That Excess phosphorus oxychloride is then distilled off in vacuo and the residue decomposed with a mixture of ice and ether. The ether layer is dehydrated with sodium sulfate and filtered off. The ether is distilled off and the residue is fractionated in vacuo.

2,6-Dichlor-5-fluorpyrimidin geht im Vakuum von 16 Torr bei 75 bis 80"C über. 2,6-dichloro-5-fluoropyrimidine goes in a vacuum of 16 torr at 75 to 80 "C about.

Ausbeute: 570 mg; F.: 38° C. Yield: 570 mg; F .: 38 ° C.

Claims (1)

Patentanspruch: Verfahren zur Herstellung von 2,6-Dichlor-5-fluorpyrimidin, dadurch gekennzeichn e t, daß man ein 1-Alkyl-5-fluoruracil in Gegenwart von Phosphorsäure bzw. geringen Mengen Wasser mit Phosphoroxychlorid bei Rückflußtemperatur umsetzt. Claim: Process for the production of 2,6-dichloro-5-fluoropyrimidine, characterized in that a 1-alkyl-5-fluorouracil is used in the presence of phosphoric acid or small amounts of water are reacted with phosphorus oxychloride at reflux temperature. In Betracht gezogene Druckschriften: Britische Patentschrift Nr. 877 318; »Journal of American Chemical Societya, Bd. 79 1957, 5. 455914560. Documents considered: British Patent No. 877 318; Journal of American Chemical Societya, Vol. 79 1957, pp. 455914560.
DER36298A 1963-10-09 1963-10-09 Process for the preparation of 2,6-dichloro-5-fluoropyrimidine Pending DE1264445B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DER36298A DE1264445B (en) 1963-10-09 1963-10-09 Process for the preparation of 2,6-dichloro-5-fluoropyrimidine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DER36298A DE1264445B (en) 1963-10-09 1963-10-09 Process for the preparation of 2,6-dichloro-5-fluoropyrimidine

Publications (1)

Publication Number Publication Date
DE1264445B true DE1264445B (en) 1968-03-28

Family

ID=7404869

Family Applications (1)

Application Number Title Priority Date Filing Date
DER36298A Pending DE1264445B (en) 1963-10-09 1963-10-09 Process for the preparation of 2,6-dichloro-5-fluoropyrimidine

Country Status (1)

Country Link
DE (1) DE1264445B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB877318A (en) * 1959-06-03 1961-09-13 Hoffmanni La Roche & Co Ag F The manufacture of cytidines

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB877318A (en) * 1959-06-03 1961-09-13 Hoffmanni La Roche & Co Ag F The manufacture of cytidines

Similar Documents

Publication Publication Date Title
EP0055695A1 (en) Process for preparing N-phosphonomethyl glycine
DE2027089A1 (en) Process for the production of phosphorus-containing polyols for the production of flame-resistant and hydrolysis-resistant polyurethanes and storage-stable premixes which can be used therefor
DE1264445B (en) Process for the preparation of 2,6-dichloro-5-fluoropyrimidine
DE850752C (en) Process for the preparation of 1,3-oxido-2-oxymethyl-2-halomethylpropane
DE2907773A1 (en) METHOD FOR PRODUCING DIAZINONE
DE1018053B (en) Process for the preparation of S-chlorobenzyl esters of O, O-dialkyl-thiolphosphoric acid
DE1950075C2 (en) Process for the preparation of 4-chloropyrazolo- square bracket to 3,4-square bracket to pyrimidine
DE2003600C3 (en) Aldolization products from isobutyraldehyde and glyoxal and process for the preparation of aldolization products
DE695317C (en) Process for obtaining the adenosine from the corresponding picrate
DE958022C (en) Process for the preparation of trichloroalkyl phosphates
DE556145C (en) Process for the preparation of organic phosphorus compounds
DE2233489B2 (en) Process for the preparation of octachlorodipropyl ether
DE1443577A1 (en) Process for the production of glycol monoesters
CH455838A (en) Process for the preparation of acylphenylacetamino-1,3-propanediols
DE1255661B (en) Continuous process for the production of pyridine and 3-picoline
DE1296636B (en) Process for the preparation of chloropyrimidines
DE239953C (en)
DE3640356A1 (en) ISOMERIC MIXTURE OF NEW BICYCLIC PHOSPHINE ACID CHLORIDES AND A METHOD FOR THE PRODUCTION THEREOF
DD255735A1 (en) PROCESS FOR THE PREPARATION OF 5-METHYL-7-HALOGEN-6-NITRO-1,2,4-TRIAZOLO- (1,5-A) PYRIMIDINES
DE1046616B (en) Process for the preparation of Octaalkylpyrophosphorsaeuramiden
DE3013269A1 (en) METHOD FOR PRODUCING 1-ACETOXY-3-CHLORINE-PENTAN-4-ON
DE1951700A1 (en) Process for the hydrolysis of alpha-carbobenzyloxy and alpha-carboaryloxy-benzylpenicillins
DE2121832A1 (en) Di-n-alkyl phosphites - from mono-n-alkyl phosphites
DE1950075B1 (en) Process for the preparation of 4-chloropyrazolo- [3,4-d] pyrimidine
DE3403511A1 (en) Process for the preparation of diepoxyalkylurazoles